AHA convenes Capitol Hill forum on rural hospital priorities

AHA News

Rural hospital and health system leaders today received an update on their legislative and policy priorities at an AHA Rural Hospital Policy Forum before meeting with their representatives on Capitol Hill.

Sen. Chuck Grassley (R-IA), lead sponsor of the AHA-supported Rural Emergency Acute Care Hospital... read more

Topics: Access and Coverage, Advocacy and Public Policy
Tags: 340B, rural, access

A vital safety-net program

Blog

The exorbitant cost of many prescription drugs threatens providers’ ability to provide life-saving medications for millions of Americans.

That is why the 340B Drug Pricing Program, which provides discounts on drugs to some health care providers who serve large numbers of low-income and uninsured... read more

Topic: Access and Coverage
Tags: 340B, access

Hospitals, not pharmaceutical manufacturers, are preserving and protecting the safety net

Blog

A group financed by the pharmaceutical industry is hosting a meeting today on the 340B Drug Pricing Program with the goal of “Preserving the True Safety Net.” But what the meeting really will be about is the pharmaceutical industry – with their skyrocketing prescription drug prices and huge profits –... read more

Topic: Access and Coverage
Tags: 340B, Drug Pricing Program, Community benefit, access, drug prices

Changing 340B is the wrong prescription for addressing skyrocketing pharmaceutical costs

Blog

The rapidly rising costs of prescription drugs is causing significant financial challenges for patients and their care providers.

Many groups, including the AHA, are evaluating options for addressing this important issue. However, one recent proposal, which is seriously misguided, would reduce a program... read more

Topic: Access and Coverage
Tags: 340B, Drug Pricing Program, access, price, drug prices

Amid concerns of possible policy changes, hospitals brief Congress on 340B's benefits

AHA News

At an AHA-sponsored briefing Nov. 19 on Capitol Hill, hospital leaders urged Congress to protect the 340B Drug Pricing Program, and shared with congressional staff the benefits that the program brings to vulnerable patients.

“People within the communities that Trinity Health serves receive tremendous and... read more

Topics: Access and Coverage, Advocacy and Public Policy
Tags: 340B, Drug Pricing Program, access

Protect Patients. Preserve 340B.

Blog

More than 20 years ago, Congress created the 340B Drug Pricing Program to allow eligible hospitals and health systems to stretch limited resources and expand access to care for vulnerable patients. But despite a proven track record of increasing patient access to vital medical services and decreasing... read more

Topic: Access and Coverage
Tags: 340B, Drug Pricing Program, access, price, drug prices

340B Proposals Would Jeopardize Hospitals' Ability to Serve Vulnerable Patients

Blog

The 340B Drug Pricing Program has a strong track record of helping to combat high prescription drug prices and increase access to vital medicines and comprehensive health care services for our nation’s most vulnerable individuals.

However, we are concerned that recent policy changes proposed by the... read more

Topic: Access and Coverage
Tags: 340B, Drug Pricing Program, drug prices

Court ruling on 340B drug case draws AHA's ire

AHA News

The AHA last week said it is “very disappointed” with a federal court decision that will exclude all drugs with an “orphan” designation from the 340B Drug Pricing Program for rural and cancer hospitals.

Denying rural and cancer hospitals access to these 340B discounts will “reduce access to critical... read more

Topics: Access and Coverage, Advocacy and Public Policy
Tags: 340B, access

GAO Report Misses Mark on 340B Program

Blog

A July 6 Government Accountability Office (GAO) report examining Medicare Part B spending at hospitals participating in the 340B Drug Pricing Program draws unsubstantiated conclusions about a program that has a proven track record of improving access to care for poor patients and vulnerable communities.... read more

Topic: Access and Coverage
Tags: 340B, Drug Pricing Program, access

AHA responds to latest effort by pharmaceutical industry to disparage 340B program

Blog

A report paid for by a group backed by the pharmaceutical industry is the latest in a series of attempts to misrepresent a program that has a proven track record of helping poor patients and vulnerable communities.

For more than 20 years, the 340B Drug Pricing Program has provided financial relief from... read more

Topic: Access and Coverage
Tags: 340B, Drug Pricing Program, access

Keyword Search

Date